perrigo co


Perrigo Reports Record Revenue; Acquisition Charges Ding Profits

The generic drug and store brand health products maker Perrigo Co. (Nasdaq: PRGO) Wednesday reported record revenue of $919.8 million in the third fiscal quarer ended March 30, up from $778 million a year earlier.

WWJ Newsradio 950–05/08/2013


Perrigo Starting Shipments of Guaifenesin Extended-Release 600mg

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers

WWJ Newsradio 950–03/18/2013


Perrigo Announces Quarterly Dividend

Perrigo Co. (Nasdaq: PRGO) Thursday announced that its board of directors declared a quarterly dividend of 9 cents a share.

WWJ Newsradio 950–01/31/2013


14 Companies To Add 4,590 Michigan Jobs, Invest $1.1 Billion

The Michigan Strategic Fund Wednesday approved state incentives to support 14 business expansions that are expected to generate more than $1.1 billion in investments and add 4,590 jobs in Michigan.

WWJ Newsradio 950–01/23/2013


Perrigo Launches Store Brand Version Of Nicorette Mini Nicotine Lozenges

The Perrigo Company (Nasdaq: PRGO) announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).

WWJ Newsradio 950–01/22/2013


Perrigo Announces Commercial Launch Of Betamethasone Foam

Perrigo Co. Tuesday announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam, consistent with the date certain launch settlement previously announced.

WWJ Newsradio 950–01/15/2013


Perrigo Announces Launch of Authorized Generic Version of Acetadote, Plus Infant Formulas

Allegan-based Perrigo Co. announced that it has made initial shipments distributing Cumberland Pharmaceuticals Inc.’s authorized generic form of Acetadote (acetylcysteine) injection, and that it had received FDA clearance to manufacture new infant formula products.

WWJ Newsradio 950–01/07/2013

HR Notices From December 4

The latest staffing, leadership and boardroom news from Michigan’s technology-focused companies, institutions and groups

WWJ Newsradio 950–12/04/2012


Perrigo Confirms Settlement Of Generic Acetadote Injection Patent Lawsuit

The generic drug and over-the-counter health product manufacturer Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote (acetylcysteine) injection brought by Cumberland Pharmaceuticals Inc.

WWJ Newsradio 950–11/13/2012


Perrigo Closes Acquisition Of Sergeant’s Pet Care Products

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has closed the acquisition of Sergeant’s Pet Care Products Inc., a privately-held, Omaha, Neb.-based manufacturer of over-the-counter companion animal healthcare products, for approximately $285 million in cash.

WWJ Newsradio 950–10/01/2012